Cases & Deals

i2Dx issues Convertible Promissory Notes to Biomark Capital

Clients i2Dx, Inc.

Jones Day advised i2Dx, Inc., a developer of a multimodal cloud-based diagnostic platform for the assessment of neurologicals, in connection with its issuance of Convertible Promissory Notes in a private placement to Biomark Capital.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.